Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunit (Q35076802)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunit |
scientific article |
Statements
1 reference
Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunit (English)
1 reference
Randal A Byrn
1 reference
Steven M Jones
1 reference
Hamilton B Bennett
1 reference
Chris Bral
1 reference
Michael P Clark
1 reference
Marc D Jacobs
1 reference
Ann D Kwong
1 reference
Mark W Ledeboer
1 reference
Joshua R Leeman
1 reference
Colleen F McNeil
1 reference
Mark A Murcko
1 reference
Azin Nezami
1 reference
Emanuele Perola
1 reference
Rene Rijnbrand
1 reference
Kumkum Saxena
1 reference
Alice W Tsai
1 reference
Yi Zhou
1 reference
Paul S Charifson
1 reference
29 December 2014
1 reference
1 reference
59
1 reference
3
1 reference
1569-1582
1 reference
Identifiers
1 reference
1 reference
1 reference